TransMedics Group (TMDX) Misses Q1 EPS by 32c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TMDX Hot Sheet
Join SI Premium – FREE
TransMedics Group (NASDAQ: TMDX) reported Q1 EPS of $0.30, $0.32 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $173.9 million versus the consensus estimate of $174.47 million.
GUIDANCE:
TransMedics Group sees FY2026 revenue of $727-757 million, versus the consensus of $739 million.
For earnings history and earnings-related data on TransMedics Group (TMDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verisk Analytics (VRSK) Tops Q3 EPS by 3c; Offers Guidance
- CareCloud, Inc. (CCLD) Reports In-Line Q3 EPS
- Cabaletta Bio, Inc. (CABA) Tops Q3 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
